Outcome Reflection for Immune Mediated Rejection by Utilizing AI in Cardiac Transplant During Early and Late Echocardiographic Analysis

Overview

About this study

The purpose of this study is to formulate a prospective cohort of Heart transplant patients (encompassing adult populations) who will be undergoing post heart transplant surveillance with endomyocardial biopsies.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Patients undergoing post-cardiac transplant endomyocardial biopsy.
Patients with the ability to provide informed consent and a consent for the study.
Adult patients age 18 years or older.

Exclusion Criteria:

Refusal of study participation.
Patients < 18 years of age.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 6/20/23. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Rochester, Minn. Mayo Clinic principal investigator Atta Behfar, M.D., Ph.D.	Open for enrollment	Contact information: Ischemic Heart Disease (IHD) (507) 284-4256

Mayo Clinic Location

Status

Contact

Rochester, Minn.

Mayo Clinic principal investigator

Atta Behfar, M.D., Ph.D.

Open for enrollment

Contact information:

Ischemic Heart Disease (IHD)

(507) 284-4256

More information

Publications

Publications are currently not available

Clinical Trials